다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Vanda Pharmaceuticals Inc (VNDA)
Vanda Pharmaceuticals Inc (VNDA) 뉴스

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2016/01/27	02:00	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2016/01/22	23:20	PR Newswire (US)	Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2015 Financial Results on February 10, 2016	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2016/01/16	04:35	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2016/01/11	21:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2016/01/11	20:55	PR Newswire (US)	Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2015 Results and 2016 Financial Guidance	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2016/01/11	10:33	Dow Jones News	Drugmakers Keep Raising Prices Despite Criticisms	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/12/23	07:03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/12/23	06:30	PR Newswire (US)	European Medicines Agency Accepts Fanaptum® (iloperidone) Marketing Authorization Application for the Treatment of Schizophr...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/12/22	08:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/12/22	08:27	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/12/22	06:32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/12/18	21:00	PR Newswire (US)	Kenneth Bate Joins the Board of Directors of Vanda Pharmaceuticals	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/12/18	06:01	PR Newswire (US)	Vanda Pharmaceuticals appoints Gian Piero Reverberi as Acting Chief Commercial Officer	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/12/12	08:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/11/23	21:02	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/11/13	08:00	PR Newswire (US)	Vanda Pharmaceuticals Announces Participation at Upcoming Investor Conferences	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/11/05	11:20	PR Newswire (US)	Vanda Pharmaceuticals to Participate in the Citi 2015 Global Healthcare 1x1 Conference	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/11/05	04:24	The Motley Fool	Why Vanda Pharmaceuticals' Shares Are Retreating Today	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/11/04	21:04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/11/04	06:14	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/11/04	06:01	PR Newswire (US)	Vanda Pharmaceuticals Reports Third Quarter 2015 Financial Results	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/10/16	06:00	PR Newswire (US)	Vanda Pharmaceuticals to Announce Third Quarter 2015 Financial Results on November 3, 2015	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/10/15	07:00	PR Newswire (US)	Vanda Announces Listing of a New Fanapt® Patent in the FDA Orange Book	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/10/14	19:07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/09/24	05:30	PR Newswire (US)	Vanda Announces Listing of a New Fanapt® Patent in the FDA Orange Book	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/09/16	06:10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/09/16	06:08	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/09/15	21:40	PR Newswire (US)	Biotechnology Equities under Review -- Radius Health, Hemispherx Biopharma, Seattle Genetics, Spectrum Pharma and Vanda Pharm...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/09/15	20:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:VNDA	Vanda Pharmaceuticals Inc
2015/09/15	20:00	PR Newswire (US)	Vanda Announces FDA Has Accepted for Review the Fanapt® Supplemental New Drug Application for Maintenance Treatment of Schiz...	NASDAQ:VNDA	Vanda Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:VNDA

<< 이전 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 다음 >>

US Dollar vs Sterling

JP Morgan Chase

Invesco QQQ Trust Series 1

BNP Paribas (QX)

American Express

Bank of America

Energy Select Sector SPDR

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관